Beneficial effects of antioxidant vitamins on the stenotic kidney - PubMed (original) (raw)
Beneficial effects of antioxidant vitamins on the stenotic kidney
Alejandro R Chade et al. Hypertension. 2003 Oct.
Abstract
Renal artery stenosis (RAS) may lead to renal injury, partly mediated through increased oxidative stress. However, the potential effects of chronic oral antioxidant intervention on the stenotic kidney remain unknown. This study was designed to test the hypothesis that chronic antioxidant vitamin supplementation in RAS would preserve renal function and structure. Single-kidney hemodynamics and function were quantified in vivo in pigs using electron-beam CT after 12 weeks of unilateral RAS (n=7), a similar degree of RAS orally supplemented with vitamins C (1 g) and E (100 IU/kg) (RAS+Vitamins, n=7), or controls (normal, n=7). Renal tissue was studied ex vivo using Western blotting and immunohistochemistry. Mean arterial pressure was similarly elevated in both RAS groups, while ischemic renal volume and glomerular filtration rate were similarly reduced. Renal blood flow was decreased in RAS compared with normal (326.5+/-99.9 versus 553.4+/-48.7 mL/min, respectively, P=0.01), but preserved in RAS+Vitamins (485.2+/-104.1 mL/min, P=0.3 versus normal). The marked increase in the expression of the NADPH-oxidase subunits p47phox and p67phox, nitrotyrosine, endothelial and inducible nitric oxide synthase, and nuclear factor-kappaB observed in RAS (P<0.05 versus normal) was normalized in RAS+Vitamins (P>0.1). Furthermore, trichrome staining and the expression of transforming growth factor-beta and tissue inhibitor of matrix-metalloproteinase-1 were also decreased in RAS+Vitamins. In conclusion, chronic blockade of the oxidative stress pathway in RAS using antioxidant vitamins improved renal hemodynamics and decreased oxidative stress, inflammation, and fibrosis in the ischemic kidney. These observations underscore the involvement of oxidative stress in renal injury in RAS and support a role for antioxidant vitamins in preserving the ischemic kidney.
Similar articles
- Antioxidant intervention blunts renal injury in experimental renovascular disease.
Chade AR, Rodriguez-Porcel M, Herrmann J, Zhu X, Grande JP, Napoli C, Lerman A, Lerman LO. Chade AR, et al. J Am Soc Nephrol. 2004 Apr;15(4):958-66. doi: 10.1097/01.asn.0000117774.83396.e9. J Am Soc Nephrol. 2004. PMID: 15034098 - Comparison of acute and chronic antioxidant interventions in experimental renovascular disease.
Chade AR, Krier JD, Rodriguez-Porcel M, Breen JF, McKusick MA, Lerman A, Lerman LO. Chade AR, et al. Am J Physiol Renal Physiol. 2004 Jun;286(6):F1079-86. doi: 10.1152/ajprenal.00385.2003. Epub 2004 Jan 13. Am J Physiol Renal Physiol. 2004. PMID: 14722019 - Distinct renal injury in early atherosclerosis and renovascular disease.
Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, Romero JC, Napoli C, Lerman LO. Chade AR, et al. Circulation. 2002 Aug 27;106(9):1165-71. doi: 10.1161/01.cir.0000027105.02327.48. Circulation. 2002. PMID: 12196346 - Antioxidant vitamins and their influence in diabetes mellitus.
Hasanain B, Mooradian AD. Hasanain B, et al. Curr Diab Rep. 2002 Oct;2(5):448-56. doi: 10.1007/s11892-002-0110-6. Curr Diab Rep. 2002. PMID: 12643171 Review. - Protective Role for Antioxidants in Acute Kidney Disease.
Dennis JM, Witting PK. Dennis JM, et al. Nutrients. 2017 Jul 7;9(7):718. doi: 10.3390/nu9070718. Nutrients. 2017. PMID: 28686196 Free PMC article. Review.
Cited by
- Kidney Intrinsic Mechanisms as Novel Targets in Renovascular Hypertension.
Eirin A, Chade AR, Lerman LO. Eirin A, et al. Hypertension. 2024 Feb;81(2):206-217. doi: 10.1161/HYPERTENSIONAHA.123.21362. Epub 2023 Oct 23. Hypertension. 2024. PMID: 37869904 Review. - Regulation of aging by balancing mitochondrial function and antioxidant levels.
Yoshina S, Izuhara L, Kamatani N, Mitani S. Yoshina S, et al. J Physiol Sci. 2022 Nov 15;72(1):28. doi: 10.1186/s12576-022-00853-1. J Physiol Sci. 2022. PMID: 36380272 Free PMC article. - Gout and Diet: A Comprehensive Review of Mechanisms and Management.
Zhang Y, Chen S, Yuan M, Xu Y, Xu H. Zhang Y, et al. Nutrients. 2022 Aug 26;14(17):3525. doi: 10.3390/nu14173525. Nutrients. 2022. PMID: 36079783 Free PMC article. Review. - A Boolean Model of Microvascular Rarefaction to Predict Treatment Outcomes in Renal Disease.
Williams E, Chade AR. Williams E, et al. Sci Rep. 2020 Jan 16;10(1):440. doi: 10.1038/s41598-019-57386-8. Sci Rep. 2020. PMID: 31949240 Free PMC article. - Novel therapeutic strategies for renovascular disease.
Eirin A, Textor SC, Lerman LO. Eirin A, et al. Curr Opin Nephrol Hypertens. 2019 Jul;28(4):383-389. doi: 10.1097/MNH.0000000000000513. Curr Opin Nephrol Hypertens. 2019. PMID: 31045658 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical